Literature DB >> 16767832

Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? Against the proposal.

Claus-Henning Köhne1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767832

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.

Authors:  Rebecca A Miksad; Mithat Gönen; Thomas J Lynch; Thomas G Roberts
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544

2.  Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer.

Authors:  Do Trong Khanh; Eiji Mekata; Ken-ichi Mukaisho; Tomoharu Shimizu; Takeshi Tatsuta; Hiroyuki Sugihara; Yoshihiro Endo; Yoshimasa Kurumi; Tohru Tani
Journal:  Int J Clin Oncol       Date:  2011-07-20       Impact factor: 3.402

3.  Immunological nomograms predicting prognosis and guiding adjuvant chemotherapy in stage II colorectal cancer.

Authors:  Yang Feng; Yaqi Li; Sanjun Cai; Junjie Peng
Journal:  Cancer Manag Res       Date:  2019-08-01       Impact factor: 3.989

4.  The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study.

Authors:  Michela Roberto; Giulia Arrivi; Emanuela Pilozzi; Andrea Montori; Genoveffa Balducci; Paolo Mercantini; Andrea Laghi; Debora Ierinò; Martina Panebianco; Daniele Marinelli; Silverio Tomao; Paolo Marchetti; Federica Mazzuca
Journal:  Cancer Manag Res       Date:  2022-04-07       Impact factor: 3.989

5.  Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.

Authors:  Yaqi Li; Qianlan Yao; Long Zhang; Shaobo Mo; Sanjun Cai; Dan Huang; Junjie Peng
Journal:  Oncologist       Date:  2020-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.